Dysport in Vulvodynia Phase II Study
NCT03598777
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
60
Enrollment
INDUSTRY
Sponsor class
Stopped
lack of efficacy
Conditions
Vulvodynia
Interventions
BIOLOGICAL:
Botulinum toxin type A
DRUG:
Placebo
Sponsor
Ipsen